Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyJavier Cortés, Chris Twelves, Vladimir Vladimirov et al.|The Lancet|2011Cited by 1.1k
Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neckG. Catimel, Jan B. Vermorken, Jaap Verweij et al.|Annals of Oncology|1994Cited by 259
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and CapecitabineJavier Cortés, Mary Ann Allison, Linda T. Vahdat et al.|Journal of Clinical Oncology|2010Cited by 217
Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: An EORTC—ECSG phase II clinical studyTeresa Gamucci, A.-R. Hanauske, R Paridaens et al.|Annals of Oncology|2000Cited by 26
Phase II studies with GI147211 (GI) in breast (B), colorectal (C) and non small cell lung cancer (N)J. Wanders, A.-R. Hanauske, Martine Piccart et al.|European Journal of Cancer|1997Cited by 3